# Cabaletta Bio funding: rounds and investors > Cabaletta Bio has raised $200M across 2 rounds since 2019. Investors include Cormorant Asset Management, Eli Lilly and Redmile Group. Source: https://millionrounds.com/company/cabaletta-bio (Millionrounds; every figure on the page links to its filing or article) United States · [Funded startup](https://millionrounds.com/companies) # Who invested in *Cabaletta Bio* 2 rounds we have observed, with the 5 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it. Follow Cabaletta Bio and see its new rounds in your feed. [Sign up free](https://millionrounds.com/login?join=1&why=follow&next=%2Fcompany%2Fcabaletta-bio) Biotech Healthcare Raised 6 months ago Funding summary Updated 27 Oct 2026 **$200M** raised across 2 rounds since 2019, from 2 sources **$50M** Round **$150M** Round - **Latest round:** Round, $150M May 2026 - **Step-up i:** 3× - **Investors:** 5 See who backed them ## The funding story Each circle is a round, placed by date and sized by amount. The line above is the running total. 2019 2020 2021 2022 2023 2024 2025 2026 **$50M** Round **$150M** Round - **First round:** Round, $50M - **Biggest round:** $150M - **Between rounds:** 7.3 years ## The rounds - **May 2026** Round **$150M** *5 new* [Cormorant Asset Management](https://millionrounds.com/fund/cormorant-asset-management) [Eli Lilly](https://millionrounds.com/fund/eli-lilly) [Redmile Group](https://millionrounds.com/fund/redmile-group) [Adage Capital Management](https://millionrounds.com/fund/adage-capital-management) [Bain Capital Life Sciences](https://millionrounds.com/fund/bain-capital-life-sciences) Source recorded - **Jan 2019** Round **$50M** No investor was named in the report. Reported by Bizjournals SEC filing: $50M sold, first sale Jan 2019 ## Founders and team From Cabaletta Bio's own website and the SEC filings it signed: 7 on the team. - **Anup Marda** Chief Financial Officer - **Heather Harte-Hall** Chief Compliance Officer - **Nicolette Sherman** Chief Human Resources Officer - **Steve Gavel** Chief Commercial Officer - **Michael Gerard** General Counsel - **Dan Geffken** Executive Officer i - **Steven Nichtberger** Executive Officer, Director i On the board, as filed i *Brian Daniels* *Mark Simon* ## Who was in which round The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led. **Round** 2019 **Round** 2026 [Cormorant Asset Management](https://millionrounds.com/fund/cormorant-asset-management) [Eli Lilly](https://millionrounds.com/fund/eli-lilly) [Redmile Group](https://millionrounds.com/fund/redmile-group) [Adage Capital Management](https://millionrounds.com/fund/adage-capital-management) [Bain Capital Life Sciences](https://millionrounds.com/fund/bain-capital-life-sciences) ## Everyone who backed them [Cormorant Asset Management](https://millionrounds.com/fund/cormorant-asset-management) Private equity **1** round [Eli Lilly](https://millionrounds.com/fund/eli-lilly) Corporate VC **1** round [Redmile Group](https://millionrounds.com/fund/redmile-group) VC firm **1** round [Adage Capital Management](https://millionrounds.com/fund/adage-capital-management) Asset manager **1** round [Bain Capital Life Sciences](https://millionrounds.com/fund/bain-capital-life-sciences) Private equity **1** round Missing a round, or an investor who was in one? [Tell us](https://millionrounds.com/corrections?slug=cabaletta-bio). ## Quick answers about Cabaletta Bio ### Who invested in Cabaletta Bio? Cabaletta Bio's investors include Cormorant Asset Management, Eli Lilly, Redmile Group, Adage Capital Management and Bain Capital Life Sciences. ### How much has Cabaletta Bio raised? Cabaletta Bio has raised $200M across 2 rounds since 2019. ### When did Cabaletta Bio last raise? Cabaletta Bio's most recent round was an Undisclosed round of $150M in May 2026. ### What was Cabaletta Bio's biggest round? Its most recent round, $150M in May 2026, is also its largest on record. ### Who backed Cabaletta Bio first? Cabaletta Bio's first round on record, in May 2026, was backed by Cormorant Asset Management, Eli Lilly and Redmile Group and 2 others. ### What stage is Cabaletta Bio at? Cabaletta Bio's latest named round is an Undisclosed round, in May 2026. ### Where is Cabaletta Bio based? Cabaletta Bio is based in the United States. ## Companies like Cabaletta Bio In the same sector, and raised in the last eighteen months. [**Star Therapeutics** $325M · Oct 2026](https://millionrounds.com/company/star-therapeutics)[**Prolific Machines** $105M · Oct 2026](https://millionrounds.com/company/prolific-machines)[**Promaxo** $106M · Oct 2026](https://millionrounds.com/company/promaxo)[**AI** $18M · Oct 2026](https://millionrounds.com/company/ai)[**Baba** $40M · Oct 2026](https://millionrounds.com/company/baba)[**IMIO** $19M · Oct 2026](https://millionrounds.com/company/imio) ## Find investors like these Search every investor by what they have actually funded, then narrow to your stage and market. Free. Open the investor searchOr these rounds in the app